Articles tagged with Mutational Analysis
New diagnostic methods aim to detect RNA viruses with high sensitivity and specificity, overcoming the challenge of rapid evolutionary dynamics. The techniques include mutation-tolerant screening and precise mutation discrimination.
A team led by Dr. Betty Tsao seeks to uncover the genetic drivers of childhood-onset systemic lupus erythematosus (SLE) using DNA sequencing. By analyzing more than 90 families with a history of SLE, they hope to identify rare mutations that could lead to new treatments.
Researchers discovered that a specific gene disruption led to the change in color, allowing the fungus to conserve energy. This process, called relaxed selection, is common among organisms adapting to dark conditions, influencing food security and health.
Researchers found that mutations in the CFAP410 gene change its interaction with another protein, making motor neuron cells more vulnerable to DNA damage and cell death. This discovery provides new insights into the mechanisms underlying Motor Neurone Disease and highlights potential targets for new therapies.
A new study suggests that genetic rescue of endangered species may not be as effective as previously thought, and could even introduce more harmful mutations. Analysis of Eastern massasauga rattlesnakes found more deleterious than adaptive mutations in donor animals selected for relocation.
Researchers discovered how the genome uses competition between proteins to prevent rogue retrotransposon LINE1 from causing damage. The team found that a modified protein NRBP2 marks and disposes of another protein NRBP1, which is no longer functional due to mutations.
The BA.2.86 Omicron strain was found to have emerged with a high number of genetic mutations in its spike protein, but failed to become a dominant strain. Its sporadic global detection has raised questions about the possibility of laboratory involvement in its emergence.
Researchers at Cold Spring Harbor Laboratory have developed a unified theory for gauge freedoms in models of biological sequences, which could revolutionize fields like plant breeding and drug development. The new approach provides efficient formulas for scientists to interpret research results with greater confidence.
Researchers identify colibactin, a bacterial toxin that alters DNA, as a potential trigger for early-onset colorectal cancer. Exposure to colibactin in childhood may imprint a distinct genetic signature on colon cells, increasing the risk of developing cancer before age 50.
Researchers analyzed CRC tumors with high tumor mutation burden to characterize BRAF-associated mutations and decipher their role in carcinogenesis. They found TMB-high tumors likely arise from a heterogeneous population of cells harboring numerous gene mutations distinct from driver oncogenes.
Researchers uncover Achilles' heel of TMZ chemotherapy resistance, revealing critical insights into mechanisms behind glioblastoma's inactivation of DNA repair pathways. The study sheds light on potential mechanisms of aging and offers new avenues for developing more effective therapies against this devastating cancer.
Researchers found nearly all women with breast cancer-like mutations carried the anomalies in luminal cells, which line the lobules and ducts. The study suggests that these rare genetic alterations could prime or predispose these cells to cancer development.
More than 70 hematology researchers from the University of Miami Miller School of Medicine will showcase their work at the 66th ASH Annual Meeting & Exposition. Researchers from Sylvester Comprehensive Cancer Center are authors or co-authors on a significant number of posters presented during the event.
A recent study discovered that COI1 proteins in maize balance growth and defense by degrading JAZ and DELLAs. This finding could lead to developing more resilient maize varieties. The research revealed an unexpected role of COI1 in regulating DELLA levels, enabling maize to thrive under hot and arid climates.
A new study has identified specific RNAs that may help identify stage II colon cancer patients who are likely to benefit from chemotherapy following surgery. The researchers found that certain housekeeping RNAs were up-regulated in patients with recurrence, suggesting their potential role in the metastatic process.
Researchers found that Werner syndrome mice experience age-dependent and sex-specific changes in their livers and immune systems, including fatty liver accumulation and altered lipid metabolism. These findings suggest a potential link between immunoglobulin variants and fatty liver progression in the disorder.
Researchers at UC Berkeley have identified two sets of genetic mutations associated with lupus, enabling the development of targeted therapies. The discoveries could lead to more effective treatments for patients with oversensitive TLRs and TLR7 receptors.
Researchers have discovered the gene responsible for producing a unique type of chlorophyll in marine algae. This breakthrough could lead to improved crop yields on less land, making it a key step towards achieving a more sustainable food supply. The study also demonstrated that a land plant can produce this specific type of chlorophyll.
Researchers developed an oxidative stress-based prognostic model for bladder cancer, identifying distinct molecular subtypes and predicting patient outcomes. The model shows promise in tailoring personalized treatment approaches, particularly for patients with low-risk profiles.
A study published in Oncotarget has identified specific mutational and therapeutic landscapes of pancreatic cancer in the Russian population. By applying machine learning models to full exome individual data, researchers received personalized recommendations for targeted treatment options for each clinical case.
A recent study published in Cell Genomics has uncovered the quantitative and qualitative mutational impacts of ionizing radiation on normal cells. The research team found that exposure to low levels of radiation resulted in an average of 14 mutations per cell, primarily causing short base deletions and complex genomic rearrangements.
Researchers report a case of a patient with EGFR L858R mutant non-small cell lung cancer (NSCLC) who experienced durable disease improvement after empirical treatment with osimertinib. The 'Lazarus effect' refers to the phenomenon where cancer appears to recur after seeming to be in remission.
Researchers analyzed LTBR expression levels in various cancers, finding it associated with low patient survival and immune cell infiltration. The study identified LTBR as a potential target for cancer immunotherapy and marker of poor prognosis.
Scientists have identified 77 main cell types and around 650 cell subtypes in a single experiment, enabling research on embryonic malformations. The new approach reduces the number of animals used for analysis and allows for faster and more accurate study of genetic disorders.
Researchers found that cancer cells with multiple mutations alter cell competition, allowing them to infiltrate and form highly invasive tumors. The study identified a key mechanism, MMP21, which promotes the production of diffusely invasive cancer cells.
Novel vaccine candidates using Computationally Optimized Broadly Reactive Antigens (COBRAs) protect against multiple influenza B strains, including those from different lineages. These vaccines show long-lasting protection, potentially reducing the need for yearly updates.
The discovery sheds light on the mechanism of phosphate release from actin filaments, which is crucial for cell movement and disassembly. The researchers found that phosphate escapes through a molecular backdoor in the filament core, but the door remains closed for most of the time.
Researchers have found a link between the antiviral drug molnupiravir and a pattern of mutations in the SARS-CoV-2 virus. The study used global sequencing databases to map mutations over time, identifying a mutational signature associated with individuals who took molnupiravir.
Researchers report a case of a 15-year-old boy with recurrent intrathoracic synovial sarcoma who achieved partial response with BRAF inhibitor Vemurafenib treatment. The study highlights the importance of routine next-generation sequencing to drive treatment choice and investigate BRAF mutations in SS tumors.
Researchers at Boyce Thompson Institute discovered a unique tomato mutation that unlocks the potential for enhanced fruit quality and stress resistance. The mutation, called 'adpressa', shows major transcriptional and metabolic adjustments, including increased levels of soluble sugars and enhanced growth.
Researchers identified a novel high RS gene, SSIIIb, which when combined with the loss-of-function SSIIIa gene, increased RS content in cooked rice. This breakthrough provides genetic resources for breeding high-RS rice varieties, potentially reducing obesity and related health issues.
A recent study analyzed 7,301 metastatic breast cancer patients with MTAP loss, revealing younger age, higher TNBC cases, and BRCA1 mutations. The findings also suggest potential therapeutic agents targeting PRMT5 and MTA2 in MTAP-deficient cancers.
Researchers developed a computational analysis method to detect and identify somatic SVs in leukemia patients, gaining insights into molecular consequences and potential therapies. The approach enables understanding of individual somatic mutations and may lead to targeted treatments.
A study by Rockefeller University scientists found that older male fruit flies are more likely to pass mutations onto their offspring due to less efficient mutation repair mechanisms. This could have implications for inherited-disease risk in humans.
Researchers found that a genetic mutation associated with liver disease confers different levels of risk depending on a patient's diabetic status. In diabetic patients, the mutation predisposes them to nonalcoholic fatty liver disease, but in nondiabetic patients, it protects against liver disease.
A new study analyzed tumor biopsies from patients with newly-diagnosed germinal center B cell lymphoma and found that CREBBP mutations were associated with lower disease-free survival rates. The researchers identified CLMA as a practical tool to translate experimental findings into clinical applications.
Researchers discovered a pattern of DNA mutations that links bladder cancer to tobacco smoking using a powerful new machine learning tool. The tool identified four mutational signatures, including one tied to tobacco smoking, which could lead to more customized treatments for patients with specific cancers.
Researchers at USC discovered that the COVID-19 virus uses a human enzyme to accelerate its mutations, allowing it to evade vaccines and spread quickly. By understanding this mechanism, scientists can predict new variants and develop more effective vaccines.
Researchers mapped specific gene variants to their effects on cardiac cells, revealing unique responses to different mutations. This study provides insights into the development of precision-targeted interventions for dilated cardiomyopathy and other genetic heart diseases.
Researchers discovered three gene mutations that, when combined, allow rice plants to retain more seeds, increasing crop yield. The study sheds light on the emergence of cultivated rice from wild rice plants and its potential applications in improving rice cultivation.
A new computer model has been developed to rapidly scan cancer genomes and identify harmful driver mutations that contribute to tumor growth. The model, trained on genomic data from various types of cancer, found additional mutations in 5-10% of patients that could help doctors identify more effective treatment options.
Researchers at Rice University have developed a theoretical framework to explain how cancers caused by multiple genetic mutations can be identified and potentially stopped. By analyzing energy landscapes of cellular transformation pathways, they found that the most dominant pathways are favored by chance.
A recent study found that boosting the pink pigeon's numbers is not sufficient to prevent its extinction in the future. The species has a high genetic load of bad mutations, which puts it at risk of collapse if conservation efforts do not continue.
Researchers found that genetic mutations in the MAPK pathway, key to normal cell growth, can also make head and neck cancer vulnerable. Individualized genomic analysis can identify specific mutations and target drugs, offering a promising approach to precision medicine.
A recent study by KU Leuven and The Francis Crick Institute analyzed 2,658 tumor samples and found that 21% exhibited double mutations in both maternal and paternal DNA copies. This discovery sheds new light on the origin of mutations and their role in cancer development.
Researchers attribute vaccine effectiveness to mutations shared with previous variants, resulting in relatively small severe cases and deaths among vaccinated patients. The study analyzed over 200,000 genomes and found identical mutations that could serve as targets for future vaccines.
The study reveals that Omicron's spike protein mutations increase its binding affinity to human cells and evade antibodies, contributing to its increased transmissibility. The researchers aim to develop more effective treatments against Omicron and related variants using this knowledge.
A team of researchers found a connection between energy production and Alzheimer's disease in zebrafish with mutated genes. They discovered that Alzheimer's disease affects the use of oxygen within cells to produce energy, leading to severe deficiency in brain function.
A recent study by NTU Singapore and Singapore General Hospital found that mutations in the DDX3X gene are responsible for chemotherapy resistance in some blood cancer patients. The study also discovered that STAT inhibitors can effectively kill lymphoma cells with DDX3X mutations, providing hope for new treatment options.
The MAP Virtual Congress 2021 focuses on integrating tumour sample analysis into daily practice, enabling personalized treatment. Key findings include actionable mutations in patient DNA and the role of the tumour microenvironment in metastasis.
A genetic analysis reveals that a rare type of blood cancer affecting immune T cells may be caused by exposure to smoking and aging-related mutations in blood precursor cells. The study found a potential link between the development of these tumours and second-hand smoke, suggesting cessation may prevent their occurrence.
A global collaboration has identified three groups of antibodies resistant to mutations in the SARS-CoV-2 Spike protein, which could target vulnerable sites on the protein. The study provides a framework for selecting durable antibody cocktails for COVID-19 treatment and will guide the development of more effective antibody therapies.
A multidisciplinary team reveals two structural points in the Spike protein of SARS-CoV-2 that allow the virus to deceive the immune system. These mutations can be detected and inform strategies to control the pandemic.
Researchers found niche mutations to have higher mortality than EGFR, but similar mortality to KRAS mutations. Next-generation sequencing helps identify a large panel of mutations for precise treatment selection.
Researchers analyzed TP53 mutations in human leukemia, finding that most missense variants exert a 'dominant-negative' effect reducing wild-type p53's cancer-suppressing activity. The study challenges previous hypotheses suggesting new oncogenic functions from these mutations.
Advanced breast cancer patients with detectable PIK3CA mutations in their blood show improved progression-free survival when treated with alpelisib added to fulvestrant. Liquid biopsy analysis reveals a 45% risk reduction compared to tissue biopsy.
A study found that individuals with a DCC gene mutation had reduced connectivity between brain regions involved in reward processing, leading to less impulsive behavior and lower cigarette smoking. The researchers also observed decreased volume in the striatum, a brain region critical for motivation and pleasure.
A study by researchers from Duke-NUS Medical School and Taiwan found that liver cancers exposed to Aristolochic Acids have AA-related mutations, with high prevalence in East and Southeast Asia. The findings highlight the need for public education and awareness about the dangers of AA in herbal products.
Researchers identified a novel mutation in the KIT gene that contributes to crizotinib resistance in ROS1+ non-small cell lung cancer patients. Ponatinib, a KIT tyrosine kinase inhibitor, demonstrates potential as a therapeutic option for overcoming this resistance.
Researchers at IDIBELL and ICO aim to study pathogenicity of variants in DNA repair genes MSH2 and MSH6. The funding will improve molecular diagnostics of Lynch syndrome, enabling better risk assessment and prevention measures.